7 August 2017 in PLOS ONE
To assess the effect of non-fluoride agents on the prevention of dental caries in primary dentition. Medline, Web of Science, Embase, Cochrane Library, CBM and CNKI databases were searched to identify all the relevant articles published prior to 16 December 2016. Grey literature was also searched. Randomized controlled human clinical trials in which non-fluoride agents were delivered by any method were considered. Of the 1,236 studies screened, 39 full articles were scrutinized and 14 selected for inclusion in the final sample. Five chemical agents, namely arginine, casein phosphopeptide-amorphous calcium phosphate (CPP-ACP), chlorhexidine, triclosan and xylitol were investigated in these included studies. The cariostatic effects of non-fluoride agents in vivo were evaluated in comparison with fluoride or placebos in randomized controlled trials. There is evidence that the use of certain doses of xylitol may be effective in arresting dental caries in primary dentition. However, quantitative synthesis could not be carried out because of the clinical and methodological heterogeneity of the included studies. A study at low risk of bias indicated that daily use of xylitol wipes is a useful adjunct for caries control in young children, however, this conclusion should be interpreted with caution as this study had a very limited sample size. Chlorhexidine and CPP-ACP may be more effective than a placebo in managing caries in primary dentition, but their effectiveness is borderline when compared with fluoride. Arginine-containing mint confection and 0.3% triclosan varnish were found to reduce caries development in primary teeth but the evidence was at high risk of bias. High quality randomized controlled trials are needed in order to make a conclusive recommendation.
30 September 2024 in Clinical and Translational Medicine
Introduction: Temporomandibular joint osteoarthritis (TMJ OA) is a major disease that affects maxillofacial health and is characterised by cartilage degeneration and subchondral bone remodelling. Obesity is associated with the exacerbation of pathological manifestations of TMJ OA. However, the underlying mechanism between adipose tissue and the TMJ axis remains limited.Objectives: To evaluate the effects of obesity and the adipose tissue on the development of TMJ OA.Methods: The obesity‐related metabolic changes in TMJ OA patients were detected by physical signs and plasma metabolites. The effects of adipose tissue‐derived EVs (Ad‐EVs) on TMJ OA was investigated through histological and cytological experiments as well as gene editing technology. Alterations of Ad‐EVs in obese state were identified by microRNA‐seq analysis and the mechanism by which EVs affect TMJ OA was explored in vitro and in vivo.Results: Obesity and the related metabolic changes were important influencing factors for TMJ OA. Ad‐EVs from obese mice induced marked chondrocyte apoptosis, cartilage matrix degradation and subchondral bone remodelling, which exacerbated the development of TMJ OA. Depletion of Ad‐EVs secretion by knocking out the geranylgeranyl diphosphate synthase (Ggpps) gene in adipose tissue significantly inhibited the obesity‐induced aggravation of TMJ OA. MiR‐3074‐5p played an important role in this process .Conclusions: Our work unveils an unknown link between obese adipose tissue and TMJ OA. Targeting the Ad‐EVs and the miR‐3074‐5p may represent a promising therapeutic strategy for obesity‐related TMJ OA.Key points: High‐fat‐diet‐induced obesity aggravate the progression of TMJ OA in mice. Obese adipose tissue participates in cartilage damage through the altered miRNA in extracellular vesicles. Inhibition of miR‐3074‐5p/SMAD4 pathway in chondrocyte alleviated the effect of HFD‐EVs on TMJ OA.